Jean-Pierre Sommadossi, PhD - Atea Pharmaceuticals
Atea Pharmaceuticals to Present at the 41st Annual J.P.
Jean-Pierre Sommadossi, Founder, Chief Executive Officer and Chairman, Atea Pharmaceuticals
thebenefactor
Jean-Pierre Sommadossi - Director at Kezar Life Sciences | The Org
![Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-2-modified-n6-substi- Tuted Purine Nucleotides For Hcv Treatment Sommadossi; Jean-Pierre ; et al. [Atea Pharmaceuticals, Inc.]](https://uspto.report/patent/app/20200331956/US20200331956A1-20201022-C00001.png "Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-2-modified-n6-substi- Tuted Purine Nucleotides For Hcv Treatment Sommadossi; Jean-Pierre ; et al. [Atea Pharmaceuticals, Inc.]")
Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-2-modified-n6-substi- Tuted Purine Nucleotides For Hcv Treatment Sommadossi; Jean-Pierre ; et al. [Atea Pharmaceuticals, Inc.]
Idenix Pharmaceuticals: Building a Leading Antiviral Franchise
BioCentury - Roche in $350M deal with Sommadossi's Atea for what it believes could be first oral COVID-19 antiviral
中華民國製藥發展協會
Dr. Jean-Pierre Sommadossi Ph.D. Net Worth (2023) | wallmine
Café des Entrepreneurs le 18 février 2017! - Consulat Général de France à Boston
Jean-Pierre Sommadossi, Founder, Chief Executive Officer and Chairman, Atea Pharmaceuticals
Medica RCP | HCP
Jean-Pierre Sommadossi, chairman and chief executive of Idenix... News Photo - Getty Images
Our Team - Atea Pharmaceuticals
Jean-Pierre Sommadossi - Director at Kezar Life Sciences | The Org
Phase I dose escalation pharmacokinetics of O-(chloroacetylcarbamoyl) fumagillol (TNP-470) and its metabolites in AIDS patients
AVIR stock Atea Pharmaceuticals Top stocks to buy in January - YouTube
Café des Entrepreneurs le 18 février 2017! - Consulat Général de France à Boston
Jean-Pierre Sommadossi, Atea Pharmaceuticals Inc: Profile and Biography - Bloomberg Markets
DEF 14A
Jean Sommadossi - Founder & Chief Executive Officer @ Idenix Pharmaceuticals - Crunchbase Person Profile
